Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Burning Rock Biotech Ltd ADR
(NQ:
BNR
)
5.630
+0.030 (+0.54%)
Streaming Delayed Price
Updated: 11:37 AM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Burning Rock Biotech Ltd ADR
< Previous
1
2
Next >
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
October 10, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces Changes to Management and Board of Directors
September 27, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports Second Quarter 2024 Financial Results
August 22, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
August 19, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
June 03, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
May 30, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports First Quarter 2024 Financial Results
May 29, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
May 23, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
May 14, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Publishes 2023 Annual Report on Form 20-F
April 29, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces ADS Ratio Change
April 26, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces Receipt of Notification from NASDAQ
January 04, 2024
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces Results of 2023 Annual General Meeting
December 19, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports Third Quarter 2023 Financial Results
November 30, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
November 22, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
November 20, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
October 30, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
October 15, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
September 07, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports Second Quarter 2023 Financial Results
August 31, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023
August 04, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Announces Resignation and Appointment of Directors
June 28, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
June 08, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports First Quarter 2023 Financial Results
May 30, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
April 27, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Publishes 2022 Annual Report on Form 20-F
April 20, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
March 07, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
Burning Rock provides an update on 2022 revenue guidance
January 17, 2023
From
Burning Rock Biotech Limited
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
